Elanco Animal Health Inc
General ticker "ELAN" information:
- Sector: Health Care
- Industry: Pharmaceuticals
- Capitalization: $6.2B
Elanco Animal Health Inc does not follow the US Stock Market performance with the rate: -9.5%.
Estimated limits based on current volatility of 1.8%: low 11.61$, high 12.03$
Factors to consider:
- US accounted for 44.9% of revenue in the fiscal year ended 2023-12-31
- Price in estimated range
- Earnings for 9 months up through Q3 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [9.04$, 16.08$]
- 2024-12-30 to 2025-12-30 estimated range: [11.02$, 18.51$]
Financial Metrics affecting the ELAN estimates:
- Positive: 0.10 < Non-GAAP EPS, $ of 0.89
- Negative: negative Net income
- Positive: 1.03 < Operating profit margin, % of 7.38
- Positive: -0.96 < Investing cash flow per share, $ of -0.34
- Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
- Negative: Industry operating profit margin (median), % of -70.04 <= 2.14
Short-term ELAN quotes
Long-term ELAN plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $4,765.00MM | $4,418.00MM | $4,417.00MM |
| Operating Expenses | $4,468.00MM | $4,060.00MM | $4,091.00MM |
| Operating Income | $297.00MM | $358.00MM | $326.00MM |
| Non-Operating Income | $-868.00MM | $-430.00MM | $-1,521.00MM |
| Interest Expense | $236.00MM | $241.00MM | $277.00MM |
| R&D Expense | $369.00MM | $321.00MM | $327.00MM |
| Income(Loss) | $-571.00MM | $-72.00MM | $-1,195.00MM |
| Taxes | $-88.00MM | $6.00MM | $36.00MM |
| Profit(Loss) | $-483.00MM | $-78.00MM | $-1,231.00MM |
| Stockholders Equity | $7,508.00MM | $7,289.00MM | $6,223.00MM |
| Inventory | $1,373.00MM | $1,538.00MM | $1,735.00MM |
| Assets | $16,478.00MM | $15,491.00MM | $14,362.00MM |
| Operating Cash Flow | $483.00MM | $452.00MM | $271.00MM |
| Capital expenditure | $197.00MM | $184.00MM | $154.00MM |
| Investing Cash Flow | $-530.00MM | $-179.00MM | $-169.00MM |
| Financing Cash Flow | $210.00MM | $-549.00MM | $-83.00MM |
| Earnings Per Share* | $-0.97 | $-0.15 | $-2.50 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.